Benign call rate and molecular test result distribution of ThyroSeq v3.
Ohori NP, Landau MS, Carty SE, Yip L, LeBeau SO, Manroa P, Seethala RR, Schoedel KE, Nikiforova MN, Nikiforov YE.
Ohori NP, et al.
Cancer Cytopathol. 2019 Mar;127(3):161-168. doi: 10.1002/cncy.22088. Epub 2018 Dec 18.
Cancer Cytopathol. 2019.
PMID: 30561907
Free article.